Your browser doesn't support javascript.
loading
Tyrosine kinase inhibitor cabozantinib impacts dendritic and natural killer cells immune response in C38 syngeneic tumor model.
Divoux, Jordane; Rolland, Sylvie; Delille, Raphael; Levin, Clément; Martin, Vincent; Young, Pamela; Meyer-Losic, Florence; Klinz, Stephan.
Affiliation
  • Divoux J; Translational Biomarkers and Pharmacology, IPSEN, Les Ulis, France.
  • Rolland S; Translational Biomarkers and Pharmacology, IPSEN, Les Ulis, France.
  • Delille R; Translational Biomarkers and Pharmacology, IPSEN, Les Ulis, France.
  • Levin C; Investigative Pathology and Safety Biomarkers, IPSEN, Les Ulis, France.
  • Martin V; Investigative Pathology and Safety Biomarkers, IPSEN, Les Ulis, France.
  • Young P; Translational Biomarkers and Pharmacology, IPSEN, Les Ulis, France.
  • Meyer-Losic F; Translational Biomarkers and Pharmacology, IPSEN, Les Ulis, France.
  • Klinz S; Early Development & Translational Sciences, IPSEN, Cambridge, MA, USA.
Eur J Immunol ; 53(6): e2250186, 2023 06.
Article in En | MEDLINE | ID: mdl-37056029
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: Eur J Immunol Year: 2023 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: Eur J Immunol Year: 2023 Type: Article Affiliation country: France